Verition Fund Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $708K | Buy |
98,589
+56,760
| +136% | +$408K | ﹤0.01% | 2059 |
|
|
2025
Q1 | $251K | Sell |
41,829
-21,695
| -34% | -$130K | ﹤0.01% | 2298 |
|
|
2024
Q4 | $495K | Buy |
63,524
+32,296
| +103% | +$252K | ﹤0.01% | 1895 |
|
|
2024
Q3 | $337K | Buy |
31,228
+2,176
| +7% | +$23.5K | ﹤0.01% | 1902 |
|
|
2024
Q2 | $245K | Buy |
29,052
+18,204
| +168% | +$153K | ﹤0.01% | 1843 |
|
|
2024
Q1 | $72.9K | Buy |
+10,848
| New | +$72.9K | ﹤0.01% | 2003 |
|
|
2023
Q2 | – | Sell |
-11,920
| Closed | -$129K | – | 1965 |
|
|
2023
Q1 | $129K | Buy |
+11,920
| New | +$129K | ﹤0.01% | 1709 |
|